Search results
Results from the WOW.Com Content Network
In addition, the Orange Book contains therapeutic equivalence evaluations (2 character rating codes) for approved multisource prescription drug products (generic drugs). These evaluations have been prepared to serve as public information and advice to state health agencies, prescribers, and pharmacists to promote public education in the area of ...
The Drugs@FDA area of the FDA’s site lets you see if there’s any generic version of your brand-name medicine. Eban is a fan of using the FDA site’s “Orange Book,” which lets you search ...
The Physicians' Desk Reference was first published in 1947 by Medical Economics Inc., a magazine publisher founded by Lansing Chapman. [2] Medical Economics Inc. merged with Reinhold Publishing in 1966 to form Chapman-Reinhold. [3] Litton Industries, which owned the American Book Company, acquired Chapman-Reinhold in 1968. [4]
An Abbreviated New Drug Application ( ANDA) is an application for a U.S. generic drug approval for an existing licensed medication or approved drug . The ANDA is submitted to FDA's Center for Drug Evaluation and Research, Office of Generic Drugs, which provides for the review and ultimate approval of a generic drug product.
The Food and Drug Administration's update of its Orange Book added the drugs approved last month, including VIVUS' (NAS: VVUS) Qsymia and Onyx Pharmaceuticals' (NAS: ONXX) Kyprolis. But the entry ...
The Generic Product Identifier ( GPI) is a 14-character hierarchical classification system created by Wolters Kluwer's Medi-Span that identifies drugs from their primary therapeutic use down to the unique interchangeable product regardless of manufacturer or package size. The code consists of seven subsets, each providing increasingly more ...
Authorized generics compete with generic products in that they are identical to their brand counterpart in both active and inactive ingredients; [1] whereas according to the U.S. Food and Drug Administration 's Office of Generic Drugs, generic drugs are required to contain only the identical active ingredients as the brand. [2]
Rank Brand Name(s) Generic Name Sales Q1 2014 Sales ($000) Change from Q4 2013 Company(ies) Disease/Medical Use First Approval Date Patent Expiration Date; 1: Abilify